Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivastigmine Patch for Attention in PDD
NCT00988117Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2010
- Primary completion
- Apr 2011
- Modality
- Reversible Covalent Inhibitors, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of rivastigmine in Parkinson's disease dementia (PDD), sponsored by University of California, San Francisco. Started Apr 2010; status: completed.
02
Drugs
rivastigmine
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT00988117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988117.